| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Capsid Proteins | 9 | 2018 | 365 | 2.11 | Why? |
| Foot-and-Mouth Disease Virus | 6 | 2018 | 29 | 1.52 | Why? |
| Cryoelectron Microscopy | 12 | 2020 | 2372 | 1.09 | Why? |
| Capsid | 8 | 2018 | 197 | 1.05 | Why? |
| Crystallography, X-Ray | 14 | 2021 | 2689 | 1.03 | Why? |
| Viral Proteins | 8 | 2021 | 7370 | 0.82 | Why? |
| Protein Conformation | 13 | 2021 | 4386 | 0.80 | Why? |
| Lysosome-Associated Membrane Glycoproteins | 1 | 2018 | 30 | 0.78 | Why? |
| Receptors, Scavenger | 1 | 2018 | 24 | 0.78 | Why? |
| Microtechnology | 1 | 2018 | 16 | 0.76 | Why? |
| Muramidase | 1 | 2018 | 24 | 0.75 | Why? |
| DNA Viruses | 2 | 2017 | 184 | 0.75 | Why? |
| Models, Molecular | 18 | 2021 | 7616 | 0.74 | Why? |
| Antidepressive Agents, Tricyclic | 1 | 2018 | 29 | 0.74 | Why? |
| Crystallography | 1 | 2018 | 52 | 0.72 | Why? |
| Macromolecular Substances | 1 | 2018 | 103 | 0.67 | Why? |
| Foot-and-Mouth Disease | 4 | 2018 | 35 | 0.61 | Why? |
| Virion | 3 | 2018 | 1444 | 0.57 | Why? |
| Enterovirus | 1 | 2018 | 402 | 0.56 | Why? |
| Glycoproteins | 1 | 2018 | 615 | 0.50 | Why? |
| Bacteriophage phi 6 | 3 | 2019 | 20 | 0.47 | Why? |
| Ebolavirus | 1 | 2018 | 834 | 0.43 | Why? |
| Antipsychotic Agents | 1 | 2018 | 887 | 0.38 | Why? |
| Synchrotrons | 2 | 2018 | 57 | 0.37 | Why? |
| Antibodies, Viral | 18 | 2021 | 51949 | 0.36 | Why? |
| Hepatitis A virus | 2 | 2018 | 68 | 0.34 | Why? |
| Powder Diffraction | 1 | 2005 | 2 | 0.32 | Why? |
| Intranuclear Inclusion Bodies | 1 | 2005 | 5 | 0.32 | Why? |
| Spike Glycoprotein, Coronavirus | 11 | 2021 | 37182 | 0.32 | Why? |
| RNA, Double-Stranded | 2 | 2019 | 226 | 0.31 | Why? |
| Inclusion Bodies, Viral | 1 | 2005 | 32 | 0.31 | Why? |
| Drug Discovery | 1 | 2020 | 3092 | 0.31 | Why? |
| Antibodies, Neutralizing | 10 | 2021 | 25288 | 0.31 | Why? |
| Insect Viruses | 1 | 2005 | 25 | 0.31 | Why? |
| Allosteric Site | 2 | 2020 | 211 | 0.27 | Why? |
| Amino Acid Sequence | 9 | 2020 | 6049 | 0.26 | Why? |
| Infectious Anemia Virus, Equine | 1 | 2002 | 2 | 0.25 | Why? |
| Antigen-Antibody Complex | 2 | 2021 | 408 | 0.23 | Why? |
| Ions | 2 | 2018 | 73 | 0.23 | Why? |
| Viral Structural Proteins | 1 | 2005 | 491 | 0.23 | Why? |
| Antibodies, Monoclonal | 8 | 2021 | 8041 | 0.22 | Why? |
| Amino Acid Motifs | 2 | 2018 | 620 | 0.22 | Why? |
| Nucleic Acid Conformation | 2 | 2019 | 621 | 0.21 | Why? |
| DNA, Single-Stranded | 2 | 2017 | 95 | 0.21 | Why? |
| Protein Binding | 11 | 2021 | 11430 | 0.21 | Why? |
| DNA Packaging | 1 | 2019 | 1 | 0.21 | Why? |
| Liquid Crystals | 1 | 2019 | 3 | 0.21 | Why? |
| Virus Uncoating | 1 | 2018 | 10 | 0.20 | Why? |
| Open Reading Frames | 1 | 2006 | 1898 | 0.19 | Why? |
| Chimera | 1 | 2018 | 83 | 0.19 | Why? |
| Bacteriophage phi X 174 | 1 | 2018 | 6 | 0.19 | Why? |
| Electrons | 1 | 2018 | 53 | 0.18 | Why? |
| Pregnancy Trimester, First | 1 | 2020 | 366 | 0.18 | Why? |
| Flavobacterium | 1 | 2017 | 4 | 0.18 | Why? |
| Picornaviridae | 1 | 2018 | 123 | 0.18 | Why? |
| DNA, Circular | 1 | 2017 | 26 | 0.18 | Why? |
| Evolution, Molecular | 3 | 2017 | 3691 | 0.17 | Why? |
| Poliovirus Vaccines | 1 | 2017 | 85 | 0.17 | Why? |
| Oligopeptides | 1 | 2021 | 576 | 0.17 | Why? |
| Electron Microscope Tomography | 1 | 2017 | 167 | 0.17 | Why? |
| Molecular Sequence Data | 5 | 2009 | 3198 | 0.17 | Why? |
| Poliovirus | 1 | 2017 | 109 | 0.16 | Why? |
| RNA-Binding Proteins | 1 | 2004 | 1022 | 0.16 | Why? |
| Crystallization | 3 | 2009 | 331 | 0.15 | Why? |
| Protein Subunits | 2 | 2017 | 755 | 0.15 | Why? |
| Immunoglobulin G | 6 | 2021 | 21571 | 0.15 | Why? |
| Microscopy, Electron, Transmission | 1 | 2018 | 605 | 0.15 | Why? |
| Receptors, Virus | 3 | 2020 | 5659 | 0.15 | Why? |
| Image Enhancement | 1 | 2017 | 177 | 0.15 | Why? |
| Tobacco | 1 | 2017 | 274 | 0.15 | Why? |
| Microscopy, Electron | 1 | 2018 | 830 | 0.14 | Why? |
| Imaging, Three-Dimensional | 2 | 2017 | 680 | 0.14 | Why? |
| Ribosomes | 2 | 2007 | 200 | 0.14 | Why? |
| Cross Protection | 1 | 2017 | 373 | 0.14 | Why? |
| Receptors, Cell Surface | 1 | 2018 | 586 | 0.14 | Why? |
| Viral Vaccines | 4 | 2020 | 7560 | 0.14 | Why? |
| Viral Matrix Proteins | 1 | 2002 | 1243 | 0.13 | Why? |
| Binding Sites | 4 | 2020 | 6201 | 0.13 | Why? |
| Neoplasm Proteins | 1 | 2018 | 501 | 0.13 | Why? |
| Poliomyelitis | 1 | 2017 | 263 | 0.13 | Why? |
| Single-Domain Antibodies | 1 | 2020 | 744 | 0.12 | Why? |
| Neutralization Tests | 3 | 2021 | 6698 | 0.12 | Why? |
| Bacillus anthracis | 2 | 2008 | 42 | 0.11 | Why? |
| SARS Virus | 2 | 2006 | 13021 | 0.11 | Why? |
| Virus Attachment | 1 | 2018 | 1259 | 0.11 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2017 | 665 | 0.11 | Why? |
| Peptidyl-Dipeptidase A | 3 | 2020 | 9659 | 0.10 | Why? |
| Algorithms | 2 | 2017 | 7346 | 0.10 | Why? |
| Vero Cells | 6 | 2021 | 14117 | 0.10 | Why? |
| Animals | 17 | 2021 | 78931 | 0.10 | Why? |
| Cell Line | 6 | 2021 | 12040 | 0.10 | Why? |
| Sequence Homology, Amino Acid | 2 | 2020 | 945 | 0.10 | Why? |
| Virus Assembly | 2 | 2017 | 438 | 0.10 | Why? |
| Protein Folding | 2 | 2008 | 270 | 0.09 | Why? |
| CHO Cells | 2 | 2021 | 831 | 0.09 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.09 | Why? |
| Nucleoside-Phosphate Kinase | 1 | 2008 | 55 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| Binding Sites, Antibody | 2 | 2021 | 466 | 0.09 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.09 | Why? |
| Cricetulus | 2 | 2021 | 936 | 0.09 | Why? |
| Eukaryotic Initiation Factor-5 | 1 | 2007 | 1 | 0.09 | Why? |
| Eukaryotic Initiation Factor-1 | 1 | 2007 | 2 | 0.09 | Why? |
| Eukaryotic Initiation Factor-3 | 1 | 2007 | 3 | 0.09 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 127 | 0.09 | Why? |
| RNA, Viral | 4 | 2019 | 32276 | 0.09 | Why? |
| Eukaryotic Initiation Factor-2 | 1 | 2007 | 81 | 0.08 | Why? |
| Genome, Viral | 3 | 2019 | 13157 | 0.08 | Why? |
| Antigens, Viral | 3 | 2020 | 6298 | 0.08 | Why? |
| Polyproteins | 1 | 2009 | 814 | 0.08 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.08 | Why? |
| Moths | 1 | 2005 | 24 | 0.08 | Why? |
| Nucleotides | 1 | 2008 | 212 | 0.08 | Why? |
| Lysine | 1 | 2006 | 153 | 0.08 | Why? |
| Swine | 3 | 2021 | 3352 | 0.08 | Why? |
| Vaccinia virus | 1 | 2008 | 346 | 0.08 | Why? |
| Frameshift Mutation | 1 | 2006 | 158 | 0.08 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 7868 | 0.08 | Why? |
| Drug Design | 1 | 2018 | 2627 | 0.08 | Why? |
| United Kingdom | 6 | 2021 | 18046 | 0.07 | Why? |
| Immunoglobulin Fab Fragments | 2 | 2020 | 556 | 0.07 | Why? |
| Protein Structure, Tertiary | 3 | 2021 | 1565 | 0.07 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.07 | Why? |
| Biochemistry | 1 | 2006 | 86 | 0.07 | Why? |
| Health Personnel | 5 | 2021 | 29646 | 0.07 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 382 | 0.07 | Why? |
| Ultracentrifugation | 1 | 2004 | 63 | 0.07 | Why? |
| Serogroup | 2 | 2017 | 510 | 0.07 | Why? |
| Recombinant Fusion Proteins | 2 | 2020 | 919 | 0.07 | Why? |
| Frameshifting, Ribosomal | 1 | 2006 | 233 | 0.07 | Why? |
| Integrins | 1 | 2005 | 158 | 0.07 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.07 | Why? |
| Computational Biology | 2 | 2017 | 4514 | 0.07 | Why? |
| Viruses | 1 | 2017 | 2238 | 0.07 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.06 | Why? |
| Antigens, Neoplasm | 1 | 2005 | 230 | 0.06 | Why? |
| Rabbits | 3 | 2018 | 1171 | 0.06 | Why? |
| Virus Replication | 2 | 2018 | 14331 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.06 | Why? |
| Cattle | 2 | 2018 | 1336 | 0.06 | Why? |
| HEK293 Cells | 3 | 2021 | 8394 | 0.06 | Why? |
| Protein Multimerization | 2 | 2021 | 1336 | 0.06 | Why? |
| Humans | 27 | 2021 | 930598 | 0.06 | Why? |
| Gene Products, gag | 1 | 2002 | 28 | 0.06 | Why? |
| Protein Biosynthesis | 1 | 2007 | 653 | 0.06 | Why? |
| Dimerization | 1 | 2004 | 475 | 0.06 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
| Mice | 5 | 2021 | 21357 | 0.06 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.06 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.06 | Why? |
| Serpins | 1 | 2021 | 67 | 0.06 | Why? |
| Hydrogen Bonding | 1 | 2004 | 599 | 0.06 | Why? |
| Protein Interaction Domains and Motifs | 2 | 2021 | 2134 | 0.06 | Why? |
| HIV Antigens | 1 | 2002 | 102 | 0.06 | Why? |
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 95 | 0.06 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.06 | Why? |
| Cell Membrane | 1 | 2006 | 743 | 0.05 | Why? |
| RNA | 1 | 2009 | 1278 | 0.05 | Why? |
| NF-kappa B | 1 | 2008 | 1301 | 0.05 | Why? |
| Amino Acid Substitution | 2 | 2018 | 1706 | 0.05 | Why? |
| Binding, Competitive | 1 | 2020 | 264 | 0.05 | Why? |
| Antibodies, Blocking | 1 | 2021 | 174 | 0.05 | Why? |
| Multivesicular Bodies | 1 | 2018 | 10 | 0.05 | Why? |
| Simian Immunodeficiency Virus | 1 | 2002 | 251 | 0.05 | Why? |
| Microfilament Proteins | 1 | 2018 | 45 | 0.05 | Why? |
| Structure-Activity Relationship | 2 | 2021 | 2219 | 0.05 | Why? |
| Endosomal Sorting Complexes Required for Transport | 1 | 2018 | 67 | 0.05 | Why? |
| Tumor Cells, Cultured | 1 | 2018 | 254 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2020 | 616 | 0.05 | Why? |
| Bacteriophage PRD1 | 1 | 2017 | 1 | 0.05 | Why? |
| Goats | 1 | 2018 | 217 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2021 | 5814 | 0.04 | Why? |
| Apoptosis | 1 | 2008 | 2335 | 0.04 | Why? |
| Pseudomonas syringae | 1 | 2017 | 6 | 0.04 | Why? |
| Prenatal Diagnosis | 1 | 2020 | 345 | 0.04 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.04 | Why? |
| Protein Domains | 2 | 2021 | 6563 | 0.04 | Why? |
| Lakes | 1 | 2017 | 83 | 0.04 | Why? |
| Peptide Library | 1 | 2020 | 564 | 0.04 | Why? |
| Genomic Instability | 1 | 2017 | 80 | 0.04 | Why? |
| Virus Release | 1 | 2018 | 253 | 0.04 | Why? |
| Glycosylation | 1 | 2021 | 1255 | 0.04 | Why? |
| Hepatitis A | 1 | 2018 | 140 | 0.04 | Why? |
| Gene Expression | 2 | 2017 | 3332 | 0.04 | Why? |
| Single-Blind Method | 1 | 2020 | 1283 | 0.04 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2020 | 691 | 0.04 | Why? |
| Vaccine Potency | 1 | 2017 | 339 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2020 | 813 | 0.04 | Why? |
| Sodium Chloride | 1 | 2017 | 203 | 0.04 | Why? |
| Sequence Alignment | 1 | 2002 | 2109 | 0.04 | Why? |
| Endosomes | 1 | 2018 | 490 | 0.04 | Why? |
| Antibody Affinity | 1 | 2020 | 1078 | 0.04 | Why? |
| RNA, Messenger | 2 | 2007 | 5131 | 0.04 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2017 | 530 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Sample Size | 1 | 2017 | 518 | 0.04 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.03 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2021 | 2739 | 0.03 | Why? |
| Antibody Specificity | 1 | 2018 | 1328 | 0.03 | Why? |
| Protein Structure, Secondary | 2 | 2008 | 1077 | 0.03 | Why? |
| Hydrogen-Ion Concentration | 1 | 2017 | 993 | 0.03 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.03 | Why? |
| Adult | 8 | 2021 | 244371 | 0.03 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Calcium | 1 | 2017 | 708 | 0.03 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.03 | Why? |
| Viral Nonstructural Proteins | 1 | 2009 | 4810 | 0.03 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.03 | Why? |
| Cricetinae | 1 | 2018 | 3344 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Female | 9 | 2021 | 380317 | 0.03 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.03 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.03 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.03 | Why? |
| Mice, Inbred C57BL | 1 | 2021 | 5542 | 0.03 | Why? |
| Adenosine Triphosphatases | 1 | 2009 | 78 | 0.03 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.02 | Why? |
| Templates, Genetic | 1 | 2009 | 58 | 0.02 | Why? |
| Vaccines, Inactivated | 1 | 2017 | 1562 | 0.02 | Why? |
| Male | 8 | 2021 | 367725 | 0.02 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.02 | Why? |
| Eukaryotic Cells | 1 | 2008 | 6 | 0.02 | Why? |
| Prokaryotic Cells | 1 | 2008 | 15 | 0.02 | Why? |
| Vaccinia | 1 | 2008 | 32 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.02 | Why? |
| Immunization, Secondary | 1 | 2017 | 1649 | 0.02 | Why? |
| Coenzymes | 1 | 2008 | 19 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Kinetics | 1 | 2017 | 3238 | 0.02 | Why? |
| England | 1 | 2020 | 5116 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
| Codon, Initiator | 1 | 2007 | 18 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2021 | 4155 | 0.02 | Why? |
| RNA, Fungal | 1 | 2007 | 23 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Mutagenesis, Site-Directed | 1 | 2009 | 449 | 0.02 | Why? |
| Temperature | 1 | 2017 | 2305 | 0.02 | Why? |
| Protein Structure, Quaternary | 1 | 2008 | 455 | 0.02 | Why? |
| RNA, Transfer | 1 | 2006 | 66 | 0.02 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.02 | Why? |
| RNA Helicases | 1 | 2009 | 413 | 0.02 | Why? |
| Methylation | 1 | 2006 | 332 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Models, Chemical | 1 | 2007 | 332 | 0.02 | Why? |
| Saccharomyces cerevisiae | 1 | 2007 | 339 | 0.02 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 238 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Flavivirus | 1 | 2006 | 182 | 0.02 | Why? |
| 5' Untranslated Regions | 1 | 2007 | 375 | 0.02 | Why? |
| Guinea Pigs | 1 | 2005 | 420 | 0.02 | Why? |
| Movement | 1 | 2006 | 232 | 0.02 | Why? |
| Research | 1 | 2017 | 2115 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Ligands | 1 | 2005 | 1300 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Specimen Handling | 1 | 2017 | 6190 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Proteins | 1 | 2006 | 921 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| Murine hepatitis virus | 1 | 2006 | 1720 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Recombinant Proteins | 1 | 2005 | 3786 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Serine Endopeptidases | 1 | 2009 | 4606 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Signal Transduction | 1 | 2008 | 7207 | 0.01 | Why? |
| Models, Biological | 1 | 2006 | 4907 | 0.01 | Why? |
| Coronavirus | 1 | 2006 | 18339 | 0.00 | Why? |